Literature DB >> 10147126

Impact of triplicate prescribing programme on psychotropic prescribing.

A Bedikian1, M A Gill.   

Abstract

Mesh:

Substances:

Year:  1993        PMID: 10147126     DOI: 10.2165/00019053-199303020-00008

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  3 in total

1.  Guidelines for performing a pharmacoeconomic analysis.

Authors:  L M Jolicoeur; A J Jones-Grizzle; J G Boyer
Journal:  Am J Hosp Pharm       Date:  1992-07

2.  Consequences of the 1989 New York State triplicate benzodiazepine prescription regulations.

Authors:  M Weintraub; S Singh; L Byrne; K Maharaj; L Guttmacher
Journal:  JAMA       Date:  1991-11-06       Impact factor: 56.272

3.  Impact of triplicate prescription program on psychotropic prescribing patterns in long-term care facilities.

Authors:  S G Zullich; T H Grasela; J B Fiedler-Kelly; F M Gengo
Journal:  Ann Pharmacother       Date:  1992-04       Impact factor: 3.154

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.